Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The rising number of diabetes patients worldwide is affecting the needle-free diabetes treatment industry. Novel treatments that are easier to understand and administer are needed as the number of diabetics rises.
Technological innovation greatly impacts needle-free diabetes therapy. Modern equipment and technology, such as smooth insulin delivery systems, enable patients feel more comfortable and follow their treatment plan, expanding the market.
Patients' demands and adherence to treatment regimens drive the market. Patients may better adhere to their treatment plans and feel less pain when given insulin without needles.
Government diabetes management programs and healthcare facility development are driving needle-free diabetes treatment growth. Subsidies, public awareness, and proper payback processes increase the usage of innovative needle-free technology.
Businesses face a growing dilemma as people live longer. Diabetics and seniors are expanding at the same pace. As senior diabetics face increasing complications, needle-free options are becoming more important.
Consider economic factors including spending money and healthcare costs while choosing needle-free diabetes therapy. People in stable economies may be willing to spend more on modern diabetes management tools.
The needle-free diabetes treatment sector is growing due to fierce rivalry among healthcare providers. These companies are striving to innovate and gain market share. Businesses spend in research and development to develop new technologies that expand the market and provide more products.
Markets are affected by strict rules and regulations, such as health authority certifications. Market players must follow laws to gain medical and consumer trust.
Increased awareness of needle-free therapy by diabetics and healthcare professionals is crucial to the industry. Education programs raise awareness of these new ideas, making them simpler to adopt and apply.
Needle-free diabetes control devices are expensive, which worries patients and doctors. These solutions are adopted more if they are affordable and cost-effective, especially in areas with limited healthcare resources.
IoT and connection make needle-free devices more user-friendly and enhance data management. These technical advances enable better patient tracking, customized treatment strategies, and industry growth.
The accessibility of obtaining needle-free diabetes care products and their effectiveness in delivery affect market penetration. Good marketing methods offer these technology to end customers quickly and easily, expanding the market.
Needle free diabetes care Market Highlights:
Needle-Free Diabetes Care Market Overview
The Needle-Free Diabetes Care Market is anticipated to reach USD 22,138.64 Million by 2030 at 8.6% CAGR during the forecast period 2022-2030. This is because of the growing diabetes population across the globe. People are looking for needle-free options for the intake of insulin.
Diabetes may be termed as a group of metabolic disorders, caused due to insulin deficiency. Needle-free medication is growing popular because it is a modern option to administer pain-free insulin medication to the patient. The diabetic population is multiplying around the world, which is expected to drive the needle-free diabetes care market growth.
Moreover, a large share of the population is also suffering from obesity. This has led to a rise in healthcare expenditure. The government is also rendering strong support for medication facilities, which will contribute to the growth of the market. Studies show that smoking adds to the probability of having diabetes in people. Moreover, more than 60% of the global population comprises smokers. This fact is also known to increase the risk of diabetes and may fuel the growth of the needle-free healthcare market.
Covid-19 Analysis
With the rise of the Covid-19 impact, many large-scale businesses and industries suffered, except healthcare and life support products. The lockdown and physical distancing protocols have affected millions of small and big business institutions alike. The needle-less diabetes healthcare market saw a slight downfall post the pandemic, due to the lockdown and physical distancing.
However, the key companies have adopted measures to sell needle-free diabetes medication online. Moreover, people are growing aware of the need for needle-less diabetes healthcare provisions. Hence, these factors are expected to boost the growth of the needle-free diabetes care market value in the years to come.
Needle-Free Diabetes Care Market Trends
Drivers
A few factors may drive the growth of the needle-free diabetes care market share. There have been increasing cases of diabetes and obesity in the population around the globe. These cases have contributed to the hike in healthcare expenditure for the people. Moreover, the government has been rendering strong support to the development of needle-free medication for diabetes. Hence, these factors are expected to accelerate global market growth.
Opportunities
The major companies that account for the largest needle-free diabetes care market share are adopting various trends such as new product launches in the field. The advancements in technology and research are adding to its growth. Moreover, most companies are adopting R&D market trends. Hence, these factors serve as opportunities for global market growth.
Restraints
There are a few factors that may inhibit the growth of the needle-free diabetes care market. One of the most important of them is the lack of awareness among people regarding the use of needle-free healthcare. Moreover, these needle-less diabetes care products are a bit expensive. Hence, these factors may hinder market growth.
Challenges
Some factors that may challenge the key diabetes healthcare providers include the cost of needle-free products. They are quite expensive and are not affordable to the majority of the diabetic population around the globe. These needle-free care products are also not available that easily. Hence, these factors challenge the key companies of the global market.
Cumulative Growth Analysis
The needle-free diabetes care market is anticipated to grow at a high speed in the years to come. This is because of the growing diabetes population across the globe. People are looking for needle-free options for the intake of insulin.
Value Chain Analysis
People are growing aware of needle-free diabetes healthcare products. These products are growing popular because of the numerous benefits they offer, without having to hurt your skin or body. Many key companies of the market have also adopted trends such as innovations and product launches. The government is also supporting market research and development. Hence, these factors may fuel the growth of the industry in the global needle-free diabetes care market forecast.
Needle-Free Diabetes Care Market Segmentation
The global needle-free diabetes care market is classified into many segments such as device types, treatment, application, and end-user. Listed below are the needle-less diabetes healthcare market segments:
Needle-Free Diabetes Care Market By Device Types
-
Diagnostic devices
-
Instant glucose monitoring
-
Continuous glucose monitoring
-
Treatment devices
-
Insulin pen
-
Insulin patch
-
-
Insulin inhaler
-
Insulin jet injector
Needle-Free Diabetes Care Market By Treatment
-
Insulin patch
-
Inhaled insulin
-
Oral insulin
-
Others
Needle-Free Diabetes Care Market By Application
-
Insulin delivery
-
Others
Needle-Free Diabetes Care Market By End-user
-
Hospitals & clinics
-
Diagnostic centres
-
Others
Needle-Free Diabetes Care Market Regional Analysis
The regional division of the needle-free diabetes care market analysis comprises North America, Europe, Asia Pacific, and the rest of the world. Among them, North America is expected to rule over the global market over the forecast period (2022 – 2030). This is because most of the obese and diabetic population in the globe belongs to the North American region.
Moreover, there are huge changes in the lifestyle of people to maintain their health. This region will be followed by Europe, with the second-largest share in the global needle-free diabetes care industry. However, the Asia Pacific region is anticipated to witness the fastest market growth rate over the forecast period. This is because the Asia Pacific comprises a large share of the diabetic population.
Competitive Landscape
The needle-free diabetes care industry is dominated by a few companies that play a vital role in the growth of the market. These healthcare companies are called the key companies of the market. They contribute to the largest share of the market profit.
The companies account for the market profits by adopting various needle-free diabetes care market trends such as joint ventures, product launches, company expansions, and procurements. They are innovative insulin medication options for diabetic patients.
Key Players
Below are the key companies that offer needle-free diabetes care in the global market, with the location of their headquarters:
-
Medical International Technology Inc. (US)
-
European Pharma Group (Netherland)
-
Zogenix Inc. (US)
-
Antares Pharma Inc. (US)
-
Valeritas Inc. (US)
-
3M Company (US)
-
Endo International plc. (US)
-
INJEX Pharma AG (Germany)
-
Bioject Medical Technologies Inc. (US)
-
Crossject SA (France)
-
PharmaJet (US)
-
PenJet Corporation (US)
Recent Developments
-
Echo Therapeutics has developed a needle-free diabetic tester that uses a patch instead of a needle poke. The transdermal biosensor examines the blood analytes through the skin with blood drawn from the body.
-
DiaMonTech launched its diabetes monitor D-Base that measures blood glucose levels by passing an infrared ray through the skin. The levels are evaluated by monitoring the temperature changes on the skin.
-
Portal Instruments launched its jet-injection device that injects insulin into the skin through a ‘hair-thin’ stream.
Report Overview
This report delivers all the information about the growth of the global needle-free diabetes care market size in the forecast period. It also contains different sections of the market analysis to help obtain detailed information such as opportunities, challenges, drivers, Covid-19 analysis, regional analysis, competitive landscape, and others. Moreover, all the information is collected from verified primary and secondary sources to provide the expected needle-free diabetes care market outlook by the year 2030.
Geographically
-
Europe
-
Asia-Pacific
-
North America
-
Middle East & Africa
-
Rest of the world
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
